arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Cybin Inc.

HELP Health Care Biotechnology: Pharmaceutical Preparations
$10.30
▼ -2.2% Today
as of Aug 5, 16:49 ET
Last 30 days +62.50% Jun 26 → Aug 05
$5.52 $6.86 $8.21 $9.56 $10.90 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$4.45
High
$4.50
Low
$4.07
Volume
$808,406
Avg Vol
$775,709
Mkt Cap
$500M
P/E (TTM)
—
Beta
—
52w High
$9.83
52w Low
$4.07
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 4 items

Jul 25 · 15:13 Simply Wall St.
Cybin (CYBN) Stock Fair Value Moves Lower As Analysts Rework Psychedelic Sector Assumptions
Jul 17 · 09:13 Simply Wall St.
Cybin (HELP) Is Up 6.2% After Advancing HLP003 To Phase 3 And Raising US$50 Million
Jul 15 · 09:22 Insider Monkey
Is Cybin D/B/A Helus Pharma (HELP) Stock a Psychedelic Medicine Opportunity Ahead of HLP003 Trial Results?
▸ Show all 4 press releases & news Free account →

Overview

52-week range
$4.07
$9.83
100% of range
Avg surprise (last 3)
-71.9%
Avg reaction (last 1)
+2.9%
100% positive
Latest IV / EM
110%
EM ±18.4% · $10 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.10$-0.84$-0.58$-0.31$-0.05 Actual $-0.05Est $-0.05Actual $-1.02Est $-0.51Actual $-1.10Est $-0.51 Mar/2023Mar/2025Jun/2025

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 13, 2025Jun/2025 $-1.10 $-0.51 -115.7% — — earnings
Mon Jun 30, 2025Mar/2025 $-1.02 $-0.51 -100.0% — +2.9% earnings
Tue Jun 27, 2023Mar/2023 $-0.05 $-0.05 0.0% — — earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 12, 2026Jun/2026OTHER -$0.80-$1.10 +27.3%

Implied volatility — last 90 days

26%152%279%406%532% Jun 07 — IV 139% · EM ±19.3%Jun 08 — IV 316% · EM ±41.7%Jun 09 — IV 506% · EM ±63.5%Jun 10 — IV 372% · EM ±43.9%Jun 11 — IV 492% · EM ±54.3%Jun 12 — IV 199% · EM ±20.3%Jun 15 — IV 488% · EM ±35.3%Jun 16 — IV 533% · EM ±31.5%Jun 17 — IV 497% · EM ±20.7%Jun 19 — IV 124% · EM ±27.3%Jun 22 — IV 128% · EM ±26.8%Jun 23 — IV 86% · EM ±17.5%Jun 24 — IV 69% · EM ±13.8%Jun 25 — IV 147% · EM ±28.9%Jun 26 — IV 221% · EM ±42.2%Jun 29 — IV 238% · EM ±42.2%Jun 30 — IV 273% · EM ±46.9%Jul 01 — IV 272% · EM ±45.5%Jul 02 — IV 126% · EM ±20.4%Jul 03 — IV 131% · EM ±20.4%Jul 06 — IV 276% · EM ±38.3%Jul 07 — IV 210% · EM ±27.7%Jul 08 — IV 281% · EM ±35.2%Jul 09 — IV 262% · EM ±30.9%Jul 10 — IV 26% · EM ±2.9%Jul 20 — IV 80% · EM ±19.0%Jul 21 — IV 105% · EM ±24.5%Jul 22 — IV 95% · EM ±21.6%Jul 23 — IV 92% · EM ±20.7%Jul 24 — IV 90% · EM ±19.8%Jul 27 — IV 103% · EM ±21.5%Jul 28 — IV 82% · EM ±16.8%Jul 29 — IV 101% · EM ±20.2%Jul 30 — IV 75% · EM ±14.6%Jul 31 — IV 91% · EM ±17.5%Aug 03 — IV 102% · EM ±18.0%Aug 04 — IV 101% · EM ±17.4%Aug 05 — IV 110% · EM ±18.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in